SLDB
Solid Biosciences LLC
NASDAQ: SLDB · HEALTHCARE · BIOTECHNOLOGY
$7.26
+2.98% today
Updated 2026-04-30
Market cap
$733.18M
P/E ratio
—
P/S ratio
3.65x
EPS (TTM)
$-1.99
Dividend yield
—
52W range
$2 – $9
Volume
1.3M
Solid Biosciences LLC (SLDB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.20M | $-20.12M | $-43.22M | $-70.20M | $-92.71M | $-56.60M | $-77.76M | $-97.98M | $-94.18M | $-100.01M | $-156.29M |
| Capital expenditures | $392000.00 | $392000.00 | $2.28M | $7.78M | $4.39M | $899000.00 | $1.28M | $3.02M | $1.51M | $654000.00 | $1.15M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $764000.00 | $1.47M | $5.33M | $5.96M | $14.21M | $11.63M | $13.37M | $7.54M | $7.63M | $10.52M | $16.91M |
| Free cash flow | $-4.60M | $-20.51M | $-45.50M | $-77.97M | $-97.10M | $-57.50M | $-79.05M | $-100.99M | $-95.69M | $-100.67M | $-157.44M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $34.55M | $-10.32M | $78.70M | $-33.87M | $36.01M | — | — | — |